Invitrogen™ Human Siglec-7 ELISA Kit

Ref.: BL-RE-092660Manufacturer ref.: EH425RB 96 tests
€732.00 excl. VAT

Human Siglec-7 quantitates human Siglec-7 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Siglec-7.

Accession number
Molécule de récepteur inhibiteur d’adhérence 1 ; molécule de récepteur inhibiteur d’adhérence 1, siglec-7 ; AIRM1 ; AIRM-1 ; CD328 ; CDw328 ; D-siglec ; p75 ; p75/ AIRM-1 ; p75/AIRM1 ; QA79 ; protéine membranaire QA79 ; lectine similaire à l’Ig de liaison à l’acide sialique 7 ; lectine similaire à l’Ig de liaison à l’acide sialique 7 ; lectine similaire à l’immunoglobuline de liaison à l’acide sialique 7 ; lectine similaire à l’Ig de liaison à l’acide sialique 7 ; Siglec ; SIGLEC19P ; SIGLEC7 ; SIGLEC-7 ; SIGLECP2
Dose range
0.1 to 25 ng/ml
Sensitivity of the dosage
0.1 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human Siglec-7 quantitates human Siglec-7 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Siglec-7.

Human Siglec-7 quantitates human Siglec-7 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Siglec-7.

Putative adhesion molecule that mediates the dependent binding of sialic acid to cells. It binds preferably to sialic acid bound to alpha-2.3 and alpha-2.6. It also binds disialogangliosides (disialogalactosyl globoside, disialyl lactotetraosylceramide and disialyl GalNac lacttotraoslylceramide). The Sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. In the immune response, it can act as an inhibitory receptor during ligand-induced phosphorylation of tyrosine by recruiting cytoplasmic phosphatase(s) through their SH2 domain(s) that block signal transduction by dephosphorylation of signaling molecules. It mediates inhibition of cytotoxicity of natural killer cells. She can play a role in hemopoiesis. It inhibits differentiation of CD34+ cell precursors to myelomocytic cell line and leukemic myeloid cell proliferation (in vitro).

Sensitivity

Sensitivity of dosage: 0.1 ng/ml.

Measurement range

Dose range: 0.1 to 25 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: SIGLEC7.

Samples

Sample type: Plasma, Serum, Surnatant (Serum volume, 50 µl; Supernatant, 50 µl; Plasma, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17114733
Specifications
Accession numberAdhesion inhibitor receptor molecule 1 ; Adhesion inhibitor receptor molecule 1, symbol 7 ; AIRM1; AIRM-1; CD328; CDw328; D-siglec; p75; p75/ AIRM-1; p75/AIRM1; QA79; membrane protein QA79; lectin similar to l-Ig bound to sialic acid 7; lectin similar to l-
Dose range0.1 to 25 ng/ml
Sensitivity of the dosage0.1 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q9Y286
Gene symbol(s)SIGLEC7
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetSIGLEC7
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; Supernatant, 50 µl; Plasma, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH425RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.